Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona Health Sciences Center, Tucson, Arizona 85721, USA.
Toxicol Sci. 2012 Jul;128(1):103-14. doi: 10.1093/toxsci/kfs142. Epub 2012 Apr 20.
2,3,5-Tris(glutathion-S-yl)hydroquinone (TGHQ), a metabolite of benzene, catalyzes the generation of reactive oxygen species (ROS) and caspase-dependent apoptosis in human promyelocytic leukemia (HL-60) cells. We now report that TGHQ induces severe DNA damage, as evidenced by DNA ladder formation and H2AX phosphorylation. The subsequent activation of the DNA nick sensor enzyme, poly(ADP-ribose) polymerase-1 (PARP-1), leads to the rapid depletion of ATP and NAD and the concomitant formation of poly(ADP-ribosylated) proteins (PARs). PJ-34 (a PARP-1 inhibitor) completely prevented the formation of PARs, partially attenuated TGHQ-mediated ATP depletion, but had little effect on NAD depletion. Intriguingly, although z-vad-fmk (a pan-caspase inhibitor) attenuated TGHQ-induced apoptosis, cotreatment with PJ-34 led to a further decrease in apoptosis, suggesting that PARP-1 participates in caspase-dependent apoptosis. Indeed, PARP-1 inhibition reduced TGHQ-induced caspase-3, -7, and -9 activation, at least partially by attenuating cytochrome c translocation from mitochondria to the cytoplasm. In contrast, PJ-34 potentiated TGHQ-induced caspase-8 activation, suggesting that PARP-1 plays a dual role in regulating TGHQ-induced apoptosis via opposing effects on the intrinsic (mitochondrial) and extrinsic (death-receptor) pathways. PARP-1 knockdown in HL-60 cells confirmed that PARP-1 participates in effector caspase activation. Finally, PJ-34 also inhibited TGHQ-induced apoptosis-inducing factor (AIF) nuclear translocation, but neither c-jun NH(2)-terminal kinase nor p38 MAPK (p38 mitogen-activated protein kinase) activation was required for AIF translocation. In summary, TGHQ-induced apoptosis of HL-60 cells is accompanied by PARP-1, caspase activation, and AIF nuclear translocation. TGHQ-induced apoptosis appears to primarily occur via engagement of the mitochondrial-mediated pathway in a process amenable to PARP inhibition. Residual cell death in the presence of PJ-34 is likely mediated via the extrinsic apoptotic pathway.
2,3,5-三(谷胱甘肽-S- 基)对苯二酚(TGHQ)是苯的代谢物,可催化人早幼粒细胞白血病(HL-60)细胞中活性氧(ROS)的产生和半胱天冬酶依赖性凋亡。我们现在报告 TGHQ 诱导严重的 DNA 损伤,如 DNA 梯形成和 H2AX 磷酸化所证明的那样。随后,DNA 切口传感器酶多聚(ADP-核糖)聚合酶-1(PARP-1)的激活导致 ATP 和 NAD 的迅速耗竭,并伴随着聚(ADP-核糖基)蛋白(PARs)的形成。PJ-34(PARP-1 抑制剂)完全阻止了 PARs 的形成,部分减弱了 TGHQ 介导的 ATP 耗竭,但对 NAD 耗竭影响很小。有趣的是,尽管 z-vad-fmk(一种半胱天冬酶抑制剂)减弱了 TGHQ 诱导的凋亡,但与 PJ-34 共同处理导致凋亡进一步减少,表明 PARP-1 参与半胱天冬酶依赖性凋亡。事实上,PARP-1 抑制降低了 TGHQ 诱导的 caspase-3、-7 和 -9 的激活,至少部分是通过减弱细胞色素 c 从线粒体向细胞质的易位来实现的。相比之下,PJ-34 增强了 TGHQ 诱导的 caspase-8 的激活,表明 PARP-1 通过对内在(线粒体)和外在(死亡受体)途径的相反作用,在调节 TGHQ 诱导的凋亡中发挥双重作用。HL-60 细胞中 PARP-1 的敲低证实 PARP-1 参与效应半胱天冬酶的激活。最后,PJ-34 还抑制了 TGHQ 诱导的凋亡诱导因子(AIF)核易位,但 AIF 易位不需要 c-jun NH2-末端激酶或 p38 MAPK(p38 丝裂原激活蛋白激酶)的激活。总之,TGHQ 诱导的 HL-60 细胞凋亡伴随着 PARP-1、半胱天冬酶的激活和 AIF 的核易位。TGHQ 诱导的凋亡似乎主要通过参与线粒体介导的途径发生,该途径易受 PARP 抑制。在 PJ-34 存在的情况下残留的细胞死亡可能通过外在凋亡途径介导。